Bordetella holmesii bacteremia in a renal transplant recipient: Emergence of a new pathogen

Transplant Infectious Disease

Volumn 14, Issue 6, 2012, Pages

  Chambaraud, T ^a   Dickson, Z ^b   Ensergueix, G ^a   Barraud, O ^a   Essig, M ^a,c   Lacour, C ^a   Allard, J ^a   Bocquentin, F ^a   Aldigier, J C ^a   Rerolle, J P ^a,c  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b Association Limousine pour l'Utlisation du Rein Artificiel à Domicile ALURAD   (France)

^c Univ Limoges   (France)

Author keywords

Bordetella holmesii; Infection; Renal transplantation; Rituximab

Indexed keywords

CEFOTAXIME; CIPROFLOXACIN; CYCLOSPORIN; RITUXIMAB; STEROID;

ACUTE KIDNEY FAILURE; ADULT; ARTHRITIS; ARTICLE; BLOOD CULTURE; BORDETELLA; BORDETELLA HOLMESII; BORDETELLOSIS; CASE REPORT; DIABETES MELLITUS; ENDOCARDITIS; FEVER; GRAFT RECIPIENT; HEMATURIA; HUMAN; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BORDETELLA; BORDETELLA INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE;

EID: 84871010138     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12009     Document Type: Article

References (15)

1. Weyant RS, Hollis DG, Weaver RE, et al. Bordetella holmesii sp. nov., a new gram-negative species associated with septicemia. J Clin Microbiol 1995; 33 (1): 1-7.
2. Shepard CW, Daneshvar MI, Kaiser RM, et al. Bordetella holmesii bacteremia: a newly recognized clinical entity among asplenic patients. Clin Infect Dis 2004; 38 (6): 799-804.
3. Lindquist SW, Weber DJ, Mangum ME, Hollis DG, Jordan J. Bordetella holmesii sepsis in an asplenic adolescent. Pediatr Infect Dis 1995; 14: 813-815.
4. Tang YW, Hopkins MK, Kolbert CP, Hartley PA, Severance PJ, Persing DH. Bordetella holmesii-like organisms associated with septicemia, endocarditis and respiratory failure. Clin Infect Dis 1998; 26: 389-392.
5. Njamkepo E, Delisle F, Hagege I, Gerbaud G, Guiso N. Bordetella holmesii isolated from a patient with sickle cell anemia: analysis and comparison with other Bordetella holmesii isolates. Clin Microbiol Infect 2000; 6: 131-136.
6. Panagopoulos MI, Saint Jean M, Brun D, et al. Bordetella holmesii bacteremia in asplenic children: report of four cases initially misidentified as Acinetobacter lwoffii. J Clin Microbiol 2010; 48 (10): 3762-3764.
7. Johnson P, Glennie M. The mechanisms of action of rituximab in the elimination of tumor cells. Semin Oncol 2003; 30 (Suppl 2): 3-8.
8. Vo AA, Lukovsky M, Toyoda M, et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 2008; 359 (3): 242-251.
9. Becker YT, Beckeer BN, Pirsch JD, Sollinger HW. Rituximab as treatment for refractory kidney transplant rejection. Am J Transplant 2004; 4: 996-100.
10. Yih WK, Silva EA, Ida J, Harrington N, Lett SM, George H. Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptoms. Emerg Infect Dis 1999; 5: 441-443.
11. Dörbecker C, Licht C, Körber F, et al. Community-acquired pneumonia due to Bordetella holmesii in a patient with frequently relapsing nephrotic syndrome. J Infect 2007; 54 (4): e203-e205.
12. Kamar N, Milioto O, Puissant-Lubrano B, et al. Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients. Am J Transplant 2010; 10 (1): 89-98.
13. McDonald V, Manns K, Mackie IJ, Machin SJ, Scully MA. Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura. J Thromb Haemost 2010; 8 (6): 1201-1208.
14. Guiard E, Karras A, Plaisier E, et al. Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab. Clin J Am Soc Nephrol 2011; 6 (7): 1609-1616.
15. Damodar A, Mustafa R, Bhatnagar J, et al. Use of anti-CD20 antibody in the treatment of post-transplant glomerulonephritis. Clin Transplant 2011; 25 (3): 375-379.